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A 42 year old man who survived sudden cardiac death 
was treated with an automatic implantable cardio-
verter/defibrillator. After a 5 month symptom-free in-
terval, the patient received two internal discharges in 
the conscious state while wearing an ambulatory electro-
cardiographic recorder. Analysis of the tape revealed 
that both discharges were activated by two bursts of 
polymorphous veptricular tachycardia, the first one oc-
The automatic implantable cardioverter/defibrillator (AleD, 
Intec Systems, Inc.) is an effective form of treatment for 
patients at risk of recurrent out-of-hospital cardiac arrest or 
other forms of hemodynamically devastating ventricular 
tachyarrhythmias (1,2). This report illustrates the reliability 
of this instrument as an anti ventricular tachycardia device 
and provides, to the best of our knowledge, the first elec-
trocardiographically documented illustration of successful 
out-of-hospital treatment of ventricular tachycardia by au-
tomatic cardioversion. It also documents a less desirable 
by-product of the device, namely, the occurrence of auto-
matic, internal discharges when symptoms of paroxysmal 
arrhythmia are minimal or nonexistent. 
Case Report 
The patient, a 42 year old white man, had a large an-
teroseptal myocardial infarction with subsequent aneurysm 
formation in 1978. He was referred to this hospital in 1980 
for management of recurrent sustained ventricular tachy-
cardia that was refractory to multiple drug trials. He was 
then referred elsewhere for surgical treatment guided by 
intraoperative mapping, but ventricular tachycardia re-
mained inducible by programmed stimulation postopera-
tively. He was placed on a regimen of quinidine and phe-
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curring at the end and the second at the onset of episodes 
of slow, hemodynamically stable monomorphous ven-
tricular tachycardia. This case illustrates the reliability 
of the automatic implantable cardioverter/defibrillator 
as an antiventricular tachycardia device and the problem 
posed by its exposure to nonsustained ventricular 
tachycardia. 
(J Am Coll CardioI1985;6:482-5) 
nytoin and suffered no recurrence until December 1983 when 
he had two episodes of ventricular tachycardia, each re-
quiring cardioversion. His plasma quinidine level was found 
to be low and the daily dose of the drug was increased. 
Cardioverter/defibrillator implantation. In April 1984, 
he sustained an episode of out-of-hospital cardiac arrest, 
requiring prolonged cardiopulmonary resuscitation and mul-
tiple direct-current shocks, from which he recovered well. 
Subsequently, the patient underwent programmed ventric-
ular electrical stimulation in a drug-free state; this induced 
sustained ventricular tachycardia at a rate of 200 beats/min. 
Antiarrhythmic therapy with amiodarone and lorcainide was 
instituted and on April 21, 1984 a cardioverter/defibrillator 
was implanted and set to intervene at a rate of tachycardia 
above 176 beats/min. After the patient's recovery from the 
thoracotomy and 18 days after initiation of combined an-
tiarrhythmic therapy, electrophysiologic testing was re-
peated and demonstrated persistent inducibility of sustained 
ventricular tachycardia. 
Two varieties of ventricular tachycardia were induced 
by double extrastimulation of the right ventricular apex: 
The first had a rate of 140 beats/min, was monomorphous 
and produced no apparent hemodynamic alteration; it was 
not terminated by the automatic device, but by a single 
programmed extrastimulus. The second variety had an initial 
rate of 225 beats/min, waS polymorphous, rapidly degen-
erated into ventricular fibrillation and was terminated by a 
single automatic shock delivered after a charge-up time of 
8.6 seconds. The patient was discharged from the hospital 
and his progress was followed up on an outpatient basis. 
Outpatient follow-up. The patient was soon able to re-
sume his usual activities and remained symptom-free until 
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October 11, 1984 when, after getting up in the morning, 
he perceived several episodes of palpitation. He reported to 
his local physician, who applied an ambulatory electrocar-
diographic monitor. A few hours later while driving his 
automobile, the patient experienced mild chest heaviness, 
soon followed by an intrathoracic shock. It was described 
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Figure 1. A, Onset of sustained mono-
morphous ventricular tachycardia. B, The 
tachycardia changes into a faster poly-
morphous rhythm and terminates spon-
taneously. C, The arrow shows the time 
of cardioverter/defibrillator discharge. See 
text for additional discussion. 
by the patient as startling, though not painful. Because he 
had suffered no apparent ill effect from the shock, he was 
advised to remain ambulatory and no change in antiar-
rhythmic therapy was recommended, pending analysis of 
the ambulatory electrocardiogram. Several hours later while 
watching television, the patient experienced a second in-
Figure 2. A, Onset of polymorphous 
tachycardia organizing itself into a 
slower monomorphous rhythm. B, The 
arrow shows the termination of ven-
tricular tachycardia by cardio-
verter/defibrillator. See text for addi-
tional discussion. 
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ternal discharge, this time not preceded by any kind of 
subjective feeling. The 24 hour electrocardiographic mon-
itor was removed the next day. 
Ambulatory electrocardiographic data. Analysis of 
the 24 hour recording disclosed the occurrence of many 
episodes of monomorphous, non sustained ventricular tachy-
cardia at rates of approximately 140 beats/min. At the time 
of the first shock, the patient had sustained, monomorphous 
ventricular tachycardia at a rate of 140 beats/min (Fig. lA) 
that lasted 78 seconds and then developed into a burst of 
self-terminating, polymorphous rhythm at an average rate 
of 200 beats/min for 5 seconds (Fig. IB). Sixteen and one 
half seconds after the spontaneous return of sinus rhythm, 
the cardioverter/defibrillator delivered its first shock (Fig. 
Ie), activated by the last few seconds of polymorphous 
ventricular tachycardia. Before receiving the second shock 
(Fig. 2B), the patient had developed a 9 second burst of 
polymorphous ventricular tachycardia at an average rate of 
190 beats/min (Fig. 2A) which developed spontaneously 
into a monomorphous, sustained rhythm at a rate of 150 
beats/min and which was effectively terminated automati-
cally by the cardioverter/defibrillator. 
The patient's serum potassium level obtained on the day 
of the monitored events measured 3.6 mEq/liter, and the 
plasma amiodarone level was 1.4 jLg/ml. He was advised 
to increase his potassium supplementation and his daily 
amiodarone dose from 400 to 600 mg. 
Discussion 
The device originally developed by Mirowski et al. (3) 
was created to treat ventricular fibrillation, and its first ver-
sion was reliably activated by ventricular rhythms producing 
a sinusoidal transcardiac signal, such as ventricular fibril-
lation or most ventricular tachycardias at rates above 200 
beats/min. It became apparent during early clinical appli-
cations, however, that a sizable proportion of patients had 
circulatory collapse from ventricular tachycardia sustained 
at rates considerably slower than 200 beats/min; such ar-
rhythmias produced nonsinusoidal transcardiac waveforms 
and were consequently left untreated. This and other prob-
lems associated with a detection system based on a broad 
bipolar recording led to the design of a new generation of 
devices that incorporate in their detection algorithm both 
the sinusoidal configuration of the signal and a critical rate 
setting measured from a local ventricular bipole of the kind 
used in conventional cardiac pacing (4). Such refinements 
have been incorporated into the most recently produced 
version of the device, the automatic implantable cardio-
verter/defibrillator, markedly increasing both its sensitivity 
and its specificity to detect ventricular tachyarrhythmias. 
The trade-off for such improvements is that it can be acti-
vated by brief episodes of nonsustained ventricular tachy-
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cardia, as illustrated by our patient. In the first instance, the 
cardioverter/defibrillator correctly remained inactive during 
the first 78 seconds of slow, minimally symptomatic ven-
tricular tachycardia, but was turned on by the last few sec-
onds of self-terminated, rapid, polymorphous ventricular 
tachycardia, finally delivering a charge during sinus rhythm. 
In the second instance, the unit was turned on by the onset 
of the episode consisting of 9 seconds of rapid, polymor-
phous ventricular tachycardia, and was therefore committed 
to terminate the asymptomatic tachycardia that followed. 
Of note is the good SUbjective tolerance of both shocks by 
our patient, and the absence of any proarrhythmic effect of 
the shock delivered during sinus rhythm. 
Clinical interpretation of cardioverter/defibrillator 
shocks. Winkle et al. (5) found it exceedingly difficult to 
determine on clinical grounds the precise reason why a shock 
has been delivered by an automatic internal cardio-
verter/defibrillator. We have also experienced this difficulty, 
particularly when shocks occur while the patient is asymp-
tomatic. In most instances, however, readmission of the 
patient to our telemetry unit has allowed the observation of 
recurrent non sustained ventricular tachycardia, and our ef-
forts, as in this case, have resulted in the suppression of 
such runs with additional antiarrhythmic therapy. Other pos-
sibilities, such as inappropriate sinus tachycardia, parox-
ysmal supraventricular tachyarrhythmias and true device 
dysfunction, must, of course, also be considered. From a 
technologic point of view, correction of this adverse effect 
would be achieved by incorporating in the detection system 
a step that would confirm the need for shock within 1 or 2 
seconds before its actual delivery. In our patient, the first 
shock would then have been prevented by the absence of 
ventricular tachycardia, and the second by the recognition 
of a tachycardia below the critical rate cut-off. The incor-
poration of such a feature represents, however, a technologic 
problem of great complexity requiring nearly beat to beat 
interpretation of the arrhythmia by the device's sensing sys-
tem. In the case of polymorphous ventricular tachycardia 
or ventricular fibrillation, rate changes and signal amplitude 
variations may be such that an ongoing average detection 
over several seconds represents a much more dependable 
scheme than a beat to beat analysis. For now, the existing 
version of the automatic internal cardioverter/defibrillator 
remains the most reliable and successful form of treatment 
for selected patients with life-threatening ventricular 
arrhythmias. 
We thank Laurie Voigt for her diligent assistance in the preparation of this 
manuscript. 
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